nodes	percent_of_prediction	percent_of_DWPC	metapath
Zoledronate—Paget's disease of bone—sarcoma	0.612	1	CtDrD
Zoledronate—ABCC1—Dactinomycin—sarcoma	0.0644	0.239	CbGbCtD
Zoledronate—ABCC1—Mitoxantrone—sarcoma	0.0576	0.214	CbGbCtD
Zoledronate—ABCC1—Epirubicin—sarcoma	0.0467	0.173	CbGbCtD
Zoledronate—ABCC1—Vincristine—sarcoma	0.0397	0.147	CbGbCtD
Zoledronate—ABCC1—Etoposide—sarcoma	0.0364	0.135	CbGbCtD
Zoledronate—ABCC1—Doxorubicin—sarcoma	0.0248	0.092	CbGbCtD
Zoledronate—FDPS—periosteum—sarcoma	0.00392	0.105	CbGeAlD
Zoledronate—CA2—periosteum—sarcoma	0.00203	0.0544	CbGeAlD
Zoledronate—GGPS1—myometrium—sarcoma	0.00179	0.0479	CbGeAlD
Zoledronate—GGPS1—seminal vesicle—sarcoma	0.00162	0.0433	CbGeAlD
Zoledronate—GGPS1—hematopoietic system—sarcoma	0.00154	0.0412	CbGeAlD
Zoledronate—GGPS1—connective tissue—sarcoma	0.00148	0.0396	CbGeAlD
Zoledronate—GGPS1—cardiac atrium—sarcoma	0.00117	0.0313	CbGeAlD
Zoledronate—GGPS1—uterus—sarcoma	0.00116	0.0311	CbGeAlD
Zoledronate—GGPS1—lymphoid tissue—sarcoma	0.00108	0.029	CbGeAlD
Zoledronate—GGPS1—tendon—sarcoma	0.00102	0.0272	CbGeAlD
Zoledronate—GGPS1—bone marrow—sarcoma	0.000986	0.0264	CbGeAlD
Zoledronate—CA14—seminal vesicle—sarcoma	0.000967	0.0259	CbGeAlD
Zoledronate—GGPS1—testis—sarcoma	0.000843	0.0226	CbGeAlD
Zoledronate—FDPS—myometrium—sarcoma	0.000826	0.0221	CbGeAlD
Zoledronate—GGPS1—liver—sarcoma	0.000797	0.0213	CbGeAlD
Zoledronate—FDPS—seminal vesicle—sarcoma	0.000746	0.02	CbGeAlD
Zoledronate—FDPS—hematopoietic system—sarcoma	0.000709	0.019	CbGeAlD
Zoledronate—CA14—cardiac atrium—sarcoma	0.000698	0.0187	CbGeAlD
Zoledronate—CA12—connective tissue—sarcoma	0.00069	0.0185	CbGeAlD
Zoledronate—FDPS—connective tissue—sarcoma	0.000683	0.0183	CbGeAlD
Zoledronate—FDPS—smooth muscle tissue—sarcoma	0.000624	0.0167	CbGeAlD
Zoledronate—FDPS—skin of body—sarcoma	0.000616	0.0165	CbGeAlD
Zoledronate—GGPS1—lymph node—sarcoma	0.000611	0.0164	CbGeAlD
Zoledronate—CA14—tendon—sarcoma	0.000608	0.0163	CbGeAlD
Zoledronate—FDPS—cardiac atrium—sarcoma	0.000538	0.0144	CbGeAlD
Zoledronate—FDPS—uterus—sarcoma	0.000535	0.0143	CbGeAlD
Zoledronate—FDPS—lymphoid tissue—sarcoma	0.000499	0.0134	CbGeAlD
Zoledronate—ABCC1—myometrium—sarcoma	0.000479	0.0128	CbGeAlD
Zoledronate—CA14—liver—sarcoma	0.000476	0.0127	CbGeAlD
Zoledronate—FDPS—tendon—sarcoma	0.000469	0.0126	CbGeAlD
Zoledronate—FDPS—bone marrow—sarcoma	0.000454	0.0122	CbGeAlD
Zoledronate—ABCC1—seminal vesicle—sarcoma	0.000433	0.0116	CbGeAlD
Zoledronate—CA2—embryo—sarcoma	0.000412	0.011	CbGeAlD
Zoledronate—FDPS—testis—sarcoma	0.000388	0.0104	CbGeAlD
Zoledronate—CA2—seminal vesicle—sarcoma	0.000387	0.0104	CbGeAlD
Zoledronate—CA2—hematopoietic system—sarcoma	0.000368	0.00985	CbGeAlD
Zoledronate—FDPS—liver—sarcoma	0.000367	0.00983	CbGeAlD
Zoledronate—CA2—connective tissue—sarcoma	0.000354	0.00949	CbGeAlD
Zoledronate—CA2—smooth muscle tissue—sarcoma	0.000324	0.00868	CbGeAlD
Zoledronate—CA2—skin of body—sarcoma	0.00032	0.00857	CbGeAlD
Zoledronate—ABCC1—cardiac atrium—sarcoma	0.000313	0.00837	CbGeAlD
Zoledronate—ABCC1—uterus—sarcoma	0.000311	0.00832	CbGeAlD
Zoledronate—FDPS—lymph node—sarcoma	0.000282	0.00754	CbGeAlD
Zoledronate—CA2—cardiac atrium—sarcoma	0.000279	0.00748	CbGeAlD
Zoledronate—ABCC1—tendon—sarcoma	0.000272	0.00729	CbGeAlD
Zoledronate—CA2—lymphoid tissue—sarcoma	0.000259	0.00694	CbGeAlD
Zoledronate—CA2—tendon—sarcoma	0.000244	0.00652	CbGeAlD
Zoledronate—CA2—bone marrow—sarcoma	0.000236	0.00632	CbGeAlD
Zoledronate—ABCC1—testis—sarcoma	0.000226	0.00604	CbGeAlD
Zoledronate—ABCC1—liver—sarcoma	0.000213	0.00571	CbGeAlD
Zoledronate—CA2—testis—sarcoma	0.000202	0.0054	CbGeAlD
Zoledronate—CA2—liver—sarcoma	0.000191	0.0051	CbGeAlD
Zoledronate—ABCC1—lymph node—sarcoma	0.000164	0.00438	CbGeAlD
Zoledronate—CA2—lymph node—sarcoma	0.000146	0.00391	CbGeAlD
Zoledronate—Hypokalaemia—Doxorubicin—sarcoma	7.97e-05	0.000987	CcSEcCtD
Zoledronate—Urticaria—Mitoxantrone—sarcoma	7.92e-05	0.000981	CcSEcCtD
Zoledronate—Anorexia—Etoposide—sarcoma	7.91e-05	0.000979	CcSEcCtD
Zoledronate—Diarrhoea—Thiotepa—sarcoma	7.9e-05	0.000979	CcSEcCtD
Zoledronate—Abdominal pain—Mitoxantrone—sarcoma	7.89e-05	0.000977	CcSEcCtD
Zoledronate—Body temperature increased—Mitoxantrone—sarcoma	7.89e-05	0.000977	CcSEcCtD
Zoledronate—Diarrhoea—Dactinomycin—sarcoma	7.84e-05	0.000971	CcSEcCtD
Zoledronate—Nasopharyngitis—Doxorubicin—sarcoma	7.83e-05	0.00097	CcSEcCtD
Zoledronate—Pancytopenia—Epirubicin—sarcoma	7.77e-05	0.000962	CcSEcCtD
Zoledronate—Hypotension—Etoposide—sarcoma	7.75e-05	0.00096	CcSEcCtD
Zoledronate—Gastritis—Doxorubicin—sarcoma	7.75e-05	0.00096	CcSEcCtD
Zoledronate—Muscular weakness—Doxorubicin—sarcoma	7.72e-05	0.000956	CcSEcCtD
Zoledronate—Neutropenia—Epirubicin—sarcoma	7.65e-05	0.000947	CcSEcCtD
Zoledronate—Dizziness—Thiotepa—sarcoma	7.64e-05	0.000946	CcSEcCtD
Zoledronate—Abdominal distension—Doxorubicin—sarcoma	7.62e-05	0.000943	CcSEcCtD
Zoledronate—Upper respiratory tract infection—Epirubicin—sarcoma	7.6e-05	0.000941	CcSEcCtD
Zoledronate—Asthma—Doxorubicin—sarcoma	7.57e-05	0.000937	CcSEcCtD
Zoledronate—Influenza—Doxorubicin—sarcoma	7.57e-05	0.000937	CcSEcCtD
Zoledronate—Dysphagia—Doxorubicin—sarcoma	7.57e-05	0.000937	CcSEcCtD
Zoledronate—Pollakiuria—Epirubicin—sarcoma	7.56e-05	0.000936	CcSEcCtD
Zoledronate—Hypersensitivity—Vincristine—sarcoma	7.55e-05	0.000935	CcSEcCtD
Zoledronate—Paraesthesia—Etoposide—sarcoma	7.45e-05	0.000923	CcSEcCtD
Zoledronate—Weight increased—Epirubicin—sarcoma	7.44e-05	0.000922	CcSEcCtD
Zoledronate—Weight decreased—Epirubicin—sarcoma	7.4e-05	0.000916	CcSEcCtD
Zoledronate—Dyspnoea—Etoposide—sarcoma	7.4e-05	0.000916	CcSEcCtD
Zoledronate—Somnolence—Etoposide—sarcoma	7.38e-05	0.000913	CcSEcCtD
Zoledronate—Hypersensitivity—Mitoxantrone—sarcoma	7.35e-05	0.00091	CcSEcCtD
Zoledronate—Asthenia—Vincristine—sarcoma	7.35e-05	0.00091	CcSEcCtD
Zoledronate—Vomiting—Thiotepa—sarcoma	7.34e-05	0.000909	CcSEcCtD
Zoledronate—Infestation—Epirubicin—sarcoma	7.29e-05	0.000903	CcSEcCtD
Zoledronate—Infestation NOS—Epirubicin—sarcoma	7.29e-05	0.000903	CcSEcCtD
Zoledronate—Vomiting—Dactinomycin—sarcoma	7.29e-05	0.000903	CcSEcCtD
Zoledronate—Rash—Thiotepa—sarcoma	7.28e-05	0.000902	CcSEcCtD
Zoledronate—Dermatitis—Thiotepa—sarcoma	7.28e-05	0.000901	CcSEcCtD
Zoledronate—Headache—Thiotepa—sarcoma	7.24e-05	0.000896	CcSEcCtD
Zoledronate—Rash—Dactinomycin—sarcoma	7.23e-05	0.000895	CcSEcCtD
Zoledronate—Decreased appetite—Etoposide—sarcoma	7.21e-05	0.000893	CcSEcCtD
Zoledronate—Pancytopenia—Doxorubicin—sarcoma	7.19e-05	0.00089	CcSEcCtD
Zoledronate—Renal failure—Epirubicin—sarcoma	7.17e-05	0.000888	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Etoposide—sarcoma	7.16e-05	0.000887	CcSEcCtD
Zoledronate—Asthenia—Mitoxantrone—sarcoma	7.16e-05	0.000886	CcSEcCtD
Zoledronate—Fatigue—Etoposide—sarcoma	7.15e-05	0.000886	CcSEcCtD
Zoledronate—Stomatitis—Epirubicin—sarcoma	7.11e-05	0.00088	CcSEcCtD
Zoledronate—Constipation—Etoposide—sarcoma	7.1e-05	0.000879	CcSEcCtD
Zoledronate—Pain—Etoposide—sarcoma	7.1e-05	0.000879	CcSEcCtD
Zoledronate—Urinary tract infection—Epirubicin—sarcoma	7.09e-05	0.000878	CcSEcCtD
Zoledronate—Conjunctivitis—Epirubicin—sarcoma	7.09e-05	0.000878	CcSEcCtD
Zoledronate—Neutropenia—Doxorubicin—sarcoma	7.08e-05	0.000876	CcSEcCtD
Zoledronate—Upper respiratory tract infection—Doxorubicin—sarcoma	7.03e-05	0.000871	CcSEcCtD
Zoledronate—Diarrhoea—Vincristine—sarcoma	7.01e-05	0.000868	CcSEcCtD
Zoledronate—Pollakiuria—Doxorubicin—sarcoma	6.99e-05	0.000866	CcSEcCtD
Zoledronate—Haematuria—Epirubicin—sarcoma	6.95e-05	0.000861	CcSEcCtD
Zoledronate—Weight increased—Doxorubicin—sarcoma	6.89e-05	0.000853	CcSEcCtD
Zoledronate—Nausea—Thiotepa—sarcoma	6.86e-05	0.00085	CcSEcCtD
Zoledronate—Weight decreased—Doxorubicin—sarcoma	6.85e-05	0.000848	CcSEcCtD
Zoledronate—Feeling abnormal—Etoposide—sarcoma	6.84e-05	0.000847	CcSEcCtD
Zoledronate—Diarrhoea—Mitoxantrone—sarcoma	6.83e-05	0.000845	CcSEcCtD
Zoledronate—Nausea—Dactinomycin—sarcoma	6.81e-05	0.000843	CcSEcCtD
Zoledronate—Agranulocytosis—Epirubicin—sarcoma	6.81e-05	0.000843	CcSEcCtD
Zoledronate—Gastrointestinal pain—Etoposide—sarcoma	6.78e-05	0.00084	CcSEcCtD
Zoledronate—Dizziness—Vincristine—sarcoma	6.77e-05	0.000839	CcSEcCtD
Zoledronate—Infestation—Doxorubicin—sarcoma	6.75e-05	0.000836	CcSEcCtD
Zoledronate—Infestation NOS—Doxorubicin—sarcoma	6.75e-05	0.000836	CcSEcCtD
Zoledronate—Bradycardia—Epirubicin—sarcoma	6.66e-05	0.000825	CcSEcCtD
Zoledronate—Renal failure—Doxorubicin—sarcoma	6.63e-05	0.000821	CcSEcCtD
Zoledronate—Urticaria—Etoposide—sarcoma	6.59e-05	0.000816	CcSEcCtD
Zoledronate—Stomatitis—Doxorubicin—sarcoma	6.58e-05	0.000814	CcSEcCtD
Zoledronate—Abdominal pain—Etoposide—sarcoma	6.56e-05	0.000812	CcSEcCtD
Zoledronate—Body temperature increased—Etoposide—sarcoma	6.56e-05	0.000812	CcSEcCtD
Zoledronate—Urinary tract infection—Doxorubicin—sarcoma	6.56e-05	0.000812	CcSEcCtD
Zoledronate—Conjunctivitis—Doxorubicin—sarcoma	6.56e-05	0.000812	CcSEcCtD
Zoledronate—Hypoaesthesia—Epirubicin—sarcoma	6.51e-05	0.000807	CcSEcCtD
Zoledronate—Vomiting—Vincristine—sarcoma	6.51e-05	0.000806	CcSEcCtD
Zoledronate—Urinary tract disorder—Epirubicin—sarcoma	6.47e-05	0.000801	CcSEcCtD
Zoledronate—Rash—Vincristine—sarcoma	6.46e-05	0.0008	CcSEcCtD
Zoledronate—Dermatitis—Vincristine—sarcoma	6.45e-05	0.000799	CcSEcCtD
Zoledronate—Oedema peripheral—Epirubicin—sarcoma	6.45e-05	0.000799	CcSEcCtD
Zoledronate—Haematuria—Doxorubicin—sarcoma	6.43e-05	0.000797	CcSEcCtD
Zoledronate—Connective tissue disorder—Epirubicin—sarcoma	6.43e-05	0.000797	CcSEcCtD
Zoledronate—Urethral disorder—Epirubicin—sarcoma	6.42e-05	0.000795	CcSEcCtD
Zoledronate—Headache—Vincristine—sarcoma	6.42e-05	0.000795	CcSEcCtD
Zoledronate—Vomiting—Mitoxantrone—sarcoma	6.34e-05	0.000785	CcSEcCtD
Zoledronate—Agranulocytosis—Doxorubicin—sarcoma	6.3e-05	0.00078	CcSEcCtD
Zoledronate—Rash—Mitoxantrone—sarcoma	6.29e-05	0.000779	CcSEcCtD
Zoledronate—Dermatitis—Mitoxantrone—sarcoma	6.28e-05	0.000778	CcSEcCtD
Zoledronate—Headache—Mitoxantrone—sarcoma	6.25e-05	0.000774	CcSEcCtD
Zoledronate—Bradycardia—Doxorubicin—sarcoma	6.17e-05	0.000764	CcSEcCtD
Zoledronate—Eye disorder—Epirubicin—sarcoma	6.12e-05	0.000758	CcSEcCtD
Zoledronate—Hypersensitivity—Etoposide—sarcoma	6.11e-05	0.000757	CcSEcCtD
Zoledronate—Nausea—Vincristine—sarcoma	6.08e-05	0.000753	CcSEcCtD
Zoledronate—Flushing—Epirubicin—sarcoma	6.08e-05	0.000752	CcSEcCtD
Zoledronate—Cardiac disorder—Epirubicin—sarcoma	6.08e-05	0.000752	CcSEcCtD
Zoledronate—Hypoaesthesia—Doxorubicin—sarcoma	6.03e-05	0.000746	CcSEcCtD
Zoledronate—Urinary tract disorder—Doxorubicin—sarcoma	5.98e-05	0.000741	CcSEcCtD
Zoledronate—Oedema peripheral—Doxorubicin—sarcoma	5.97e-05	0.000739	CcSEcCtD
Zoledronate—Asthenia—Etoposide—sarcoma	5.95e-05	0.000737	CcSEcCtD
Zoledronate—Connective tissue disorder—Doxorubicin—sarcoma	5.95e-05	0.000737	CcSEcCtD
Zoledronate—Angiopathy—Epirubicin—sarcoma	5.94e-05	0.000736	CcSEcCtD
Zoledronate—Urethral disorder—Doxorubicin—sarcoma	5.94e-05	0.000735	CcSEcCtD
Zoledronate—Nausea—Mitoxantrone—sarcoma	5.93e-05	0.000734	CcSEcCtD
Zoledronate—Immune system disorder—Epirubicin—sarcoma	5.91e-05	0.000732	CcSEcCtD
Zoledronate—Mediastinal disorder—Epirubicin—sarcoma	5.9e-05	0.000731	CcSEcCtD
Zoledronate—Chills—Epirubicin—sarcoma	5.87e-05	0.000727	CcSEcCtD
Zoledronate—Pruritus—Etoposide—sarcoma	5.87e-05	0.000727	CcSEcCtD
Zoledronate—Arrhythmia—Epirubicin—sarcoma	5.85e-05	0.000724	CcSEcCtD
Zoledronate—Alopecia—Epirubicin—sarcoma	5.78e-05	0.000716	CcSEcCtD
Zoledronate—Mental disorder—Epirubicin—sarcoma	5.74e-05	0.00071	CcSEcCtD
Zoledronate—Erythema—Epirubicin—sarcoma	5.7e-05	0.000706	CcSEcCtD
Zoledronate—Malnutrition—Epirubicin—sarcoma	5.7e-05	0.000706	CcSEcCtD
Zoledronate—Diarrhoea—Etoposide—sarcoma	5.68e-05	0.000703	CcSEcCtD
Zoledronate—Eye disorder—Doxorubicin—sarcoma	5.66e-05	0.000701	CcSEcCtD
Zoledronate—Flushing—Doxorubicin—sarcoma	5.62e-05	0.000696	CcSEcCtD
Zoledronate—Cardiac disorder—Doxorubicin—sarcoma	5.62e-05	0.000696	CcSEcCtD
Zoledronate—Dysgeusia—Epirubicin—sarcoma	5.58e-05	0.000691	CcSEcCtD
Zoledronate—Back pain—Epirubicin—sarcoma	5.51e-05	0.000683	CcSEcCtD
Zoledronate—Angiopathy—Doxorubicin—sarcoma	5.5e-05	0.000681	CcSEcCtD
Zoledronate—Dizziness—Etoposide—sarcoma	5.49e-05	0.000679	CcSEcCtD
Zoledronate—Muscle spasms—Epirubicin—sarcoma	5.48e-05	0.000678	CcSEcCtD
Zoledronate—Immune system disorder—Doxorubicin—sarcoma	5.47e-05	0.000678	CcSEcCtD
Zoledronate—Mediastinal disorder—Doxorubicin—sarcoma	5.46e-05	0.000676	CcSEcCtD
Zoledronate—Chills—Doxorubicin—sarcoma	5.44e-05	0.000673	CcSEcCtD
Zoledronate—Arrhythmia—Doxorubicin—sarcoma	5.41e-05	0.00067	CcSEcCtD
Zoledronate—Vision blurred—Epirubicin—sarcoma	5.37e-05	0.000665	CcSEcCtD
Zoledronate—Alopecia—Doxorubicin—sarcoma	5.35e-05	0.000663	CcSEcCtD
Zoledronate—Mental disorder—Doxorubicin—sarcoma	5.31e-05	0.000657	CcSEcCtD
Zoledronate—Ill-defined disorder—Epirubicin—sarcoma	5.29e-05	0.000655	CcSEcCtD
Zoledronate—Vomiting—Etoposide—sarcoma	5.28e-05	0.000653	CcSEcCtD
Zoledronate—Malnutrition—Doxorubicin—sarcoma	5.27e-05	0.000653	CcSEcCtD
Zoledronate—Erythema—Doxorubicin—sarcoma	5.27e-05	0.000653	CcSEcCtD
Zoledronate—Anaemia—Epirubicin—sarcoma	5.27e-05	0.000652	CcSEcCtD
Zoledronate—Agitation—Epirubicin—sarcoma	5.24e-05	0.000649	CcSEcCtD
Zoledronate—Rash—Etoposide—sarcoma	5.23e-05	0.000648	CcSEcCtD
Zoledronate—Dermatitis—Etoposide—sarcoma	5.23e-05	0.000647	CcSEcCtD
Zoledronate—Headache—Etoposide—sarcoma	5.2e-05	0.000644	CcSEcCtD
Zoledronate—Dysgeusia—Doxorubicin—sarcoma	5.16e-05	0.000639	CcSEcCtD
Zoledronate—Malaise—Epirubicin—sarcoma	5.14e-05	0.000636	CcSEcCtD
Zoledronate—Vertigo—Epirubicin—sarcoma	5.12e-05	0.000634	CcSEcCtD
Zoledronate—Syncope—Epirubicin—sarcoma	5.11e-05	0.000633	CcSEcCtD
Zoledronate—Leukopenia—Epirubicin—sarcoma	5.1e-05	0.000632	CcSEcCtD
Zoledronate—Back pain—Doxorubicin—sarcoma	5.1e-05	0.000632	CcSEcCtD
Zoledronate—Muscle spasms—Doxorubicin—sarcoma	5.07e-05	0.000628	CcSEcCtD
Zoledronate—Palpitations—Epirubicin—sarcoma	5.04e-05	0.000624	CcSEcCtD
Zoledronate—Loss of consciousness—Epirubicin—sarcoma	5.01e-05	0.00062	CcSEcCtD
Zoledronate—Cough—Epirubicin—sarcoma	4.97e-05	0.000616	CcSEcCtD
Zoledronate—Vision blurred—Doxorubicin—sarcoma	4.97e-05	0.000615	CcSEcCtD
Zoledronate—Convulsion—Epirubicin—sarcoma	4.94e-05	0.000611	CcSEcCtD
Zoledronate—Nausea—Etoposide—sarcoma	4.93e-05	0.00061	CcSEcCtD
Zoledronate—Hypertension—Epirubicin—sarcoma	4.92e-05	0.000609	CcSEcCtD
Zoledronate—Ill-defined disorder—Doxorubicin—sarcoma	4.89e-05	0.000606	CcSEcCtD
Zoledronate—Anaemia—Doxorubicin—sarcoma	4.87e-05	0.000604	CcSEcCtD
Zoledronate—Arthralgia—Epirubicin—sarcoma	4.85e-05	0.000601	CcSEcCtD
Zoledronate—Chest pain—Epirubicin—sarcoma	4.85e-05	0.000601	CcSEcCtD
Zoledronate—Myalgia—Epirubicin—sarcoma	4.85e-05	0.000601	CcSEcCtD
Zoledronate—Agitation—Doxorubicin—sarcoma	4.85e-05	0.0006	CcSEcCtD
Zoledronate—Anxiety—Epirubicin—sarcoma	4.83e-05	0.000599	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	4.82e-05	0.000597	CcSEcCtD
Zoledronate—Discomfort—Epirubicin—sarcoma	4.79e-05	0.000594	CcSEcCtD
Zoledronate—Malaise—Doxorubicin—sarcoma	4.76e-05	0.000589	CcSEcCtD
Zoledronate—Dry mouth—Epirubicin—sarcoma	4.74e-05	0.000588	CcSEcCtD
Zoledronate—Vertigo—Doxorubicin—sarcoma	4.74e-05	0.000587	CcSEcCtD
Zoledronate—Syncope—Doxorubicin—sarcoma	4.73e-05	0.000586	CcSEcCtD
Zoledronate—Leukopenia—Doxorubicin—sarcoma	4.72e-05	0.000584	CcSEcCtD
Zoledronate—Confusional state—Epirubicin—sarcoma	4.69e-05	0.000581	CcSEcCtD
Zoledronate—Palpitations—Doxorubicin—sarcoma	4.66e-05	0.000577	CcSEcCtD
Zoledronate—Oedema—Epirubicin—sarcoma	4.65e-05	0.000576	CcSEcCtD
Zoledronate—Anaphylactic shock—Epirubicin—sarcoma	4.65e-05	0.000576	CcSEcCtD
Zoledronate—Loss of consciousness—Doxorubicin—sarcoma	4.63e-05	0.000574	CcSEcCtD
Zoledronate—Infection—Epirubicin—sarcoma	4.62e-05	0.000572	CcSEcCtD
Zoledronate—Cough—Doxorubicin—sarcoma	4.6e-05	0.00057	CcSEcCtD
Zoledronate—Shock—Epirubicin—sarcoma	4.58e-05	0.000567	CcSEcCtD
Zoledronate—Convulsion—Doxorubicin—sarcoma	4.57e-05	0.000566	CcSEcCtD
Zoledronate—Nervous system disorder—Epirubicin—sarcoma	4.56e-05	0.000565	CcSEcCtD
Zoledronate—Thrombocytopenia—Epirubicin—sarcoma	4.55e-05	0.000564	CcSEcCtD
Zoledronate—Hypertension—Doxorubicin—sarcoma	4.55e-05	0.000564	CcSEcCtD
Zoledronate—Tachycardia—Epirubicin—sarcoma	4.54e-05	0.000562	CcSEcCtD
Zoledronate—Skin disorder—Epirubicin—sarcoma	4.52e-05	0.000559	CcSEcCtD
Zoledronate—Hyperhidrosis—Epirubicin—sarcoma	4.5e-05	0.000557	CcSEcCtD
Zoledronate—Myalgia—Doxorubicin—sarcoma	4.49e-05	0.000556	CcSEcCtD
Zoledronate—Arthralgia—Doxorubicin—sarcoma	4.49e-05	0.000556	CcSEcCtD
Zoledronate—Chest pain—Doxorubicin—sarcoma	4.49e-05	0.000556	CcSEcCtD
Zoledronate—Anxiety—Doxorubicin—sarcoma	4.47e-05	0.000554	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	4.46e-05	0.000552	CcSEcCtD
Zoledronate—Discomfort—Doxorubicin—sarcoma	4.44e-05	0.000549	CcSEcCtD
Zoledronate—Anorexia—Epirubicin—sarcoma	4.43e-05	0.000549	CcSEcCtD
Zoledronate—Dry mouth—Doxorubicin—sarcoma	4.39e-05	0.000544	CcSEcCtD
Zoledronate—Hypotension—Epirubicin—sarcoma	4.35e-05	0.000538	CcSEcCtD
Zoledronate—Confusional state—Doxorubicin—sarcoma	4.34e-05	0.000537	CcSEcCtD
Zoledronate—Anaphylactic shock—Doxorubicin—sarcoma	4.3e-05	0.000533	CcSEcCtD
Zoledronate—Oedema—Doxorubicin—sarcoma	4.3e-05	0.000533	CcSEcCtD
Zoledronate—Infection—Doxorubicin—sarcoma	4.28e-05	0.000529	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Epirubicin—sarcoma	4.24e-05	0.000525	CcSEcCtD
Zoledronate—Shock—Doxorubicin—sarcoma	4.23e-05	0.000524	CcSEcCtD
Zoledronate—Nervous system disorder—Doxorubicin—sarcoma	4.22e-05	0.000523	CcSEcCtD
Zoledronate—Thrombocytopenia—Doxorubicin—sarcoma	4.21e-05	0.000522	CcSEcCtD
Zoledronate—Insomnia—Epirubicin—sarcoma	4.21e-05	0.000521	CcSEcCtD
Zoledronate—Tachycardia—Doxorubicin—sarcoma	4.2e-05	0.00052	CcSEcCtD
Zoledronate—Skin disorder—Doxorubicin—sarcoma	4.18e-05	0.000518	CcSEcCtD
Zoledronate—Paraesthesia—Epirubicin—sarcoma	4.18e-05	0.000517	CcSEcCtD
Zoledronate—Hyperhidrosis—Doxorubicin—sarcoma	4.16e-05	0.000515	CcSEcCtD
Zoledronate—Dyspnoea—Epirubicin—sarcoma	4.15e-05	0.000513	CcSEcCtD
Zoledronate—Somnolence—Epirubicin—sarcoma	4.13e-05	0.000512	CcSEcCtD
Zoledronate—Anorexia—Doxorubicin—sarcoma	4.1e-05	0.000508	CcSEcCtD
Zoledronate—Dyspepsia—Epirubicin—sarcoma	4.09e-05	0.000507	CcSEcCtD
Zoledronate—Decreased appetite—Epirubicin—sarcoma	4.04e-05	0.000501	CcSEcCtD
Zoledronate—Hypotension—Doxorubicin—sarcoma	4.02e-05	0.000498	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Epirubicin—sarcoma	4.02e-05	0.000497	CcSEcCtD
Zoledronate—Fatigue—Epirubicin—sarcoma	4.01e-05	0.000497	CcSEcCtD
Zoledronate—Constipation—Epirubicin—sarcoma	3.98e-05	0.000493	CcSEcCtD
Zoledronate—Pain—Epirubicin—sarcoma	3.98e-05	0.000493	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Doxorubicin—sarcoma	3.92e-05	0.000486	CcSEcCtD
Zoledronate—Insomnia—Doxorubicin—sarcoma	3.89e-05	0.000482	CcSEcCtD
Zoledronate—Paraesthesia—Doxorubicin—sarcoma	3.86e-05	0.000479	CcSEcCtD
Zoledronate—Dyspnoea—Doxorubicin—sarcoma	3.84e-05	0.000475	CcSEcCtD
Zoledronate—Feeling abnormal—Epirubicin—sarcoma	3.83e-05	0.000475	CcSEcCtD
Zoledronate—Somnolence—Doxorubicin—sarcoma	3.83e-05	0.000474	CcSEcCtD
Zoledronate—Gastrointestinal pain—Epirubicin—sarcoma	3.8e-05	0.000471	CcSEcCtD
Zoledronate—Dyspepsia—Doxorubicin—sarcoma	3.79e-05	0.000469	CcSEcCtD
Zoledronate—Decreased appetite—Doxorubicin—sarcoma	3.74e-05	0.000463	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Doxorubicin—sarcoma	3.72e-05	0.00046	CcSEcCtD
Zoledronate—Fatigue—Doxorubicin—sarcoma	3.71e-05	0.000459	CcSEcCtD
Zoledronate—Urticaria—Epirubicin—sarcoma	3.69e-05	0.000458	CcSEcCtD
Zoledronate—Constipation—Doxorubicin—sarcoma	3.68e-05	0.000456	CcSEcCtD
Zoledronate—Pain—Doxorubicin—sarcoma	3.68e-05	0.000456	CcSEcCtD
Zoledronate—Body temperature increased—Epirubicin—sarcoma	3.68e-05	0.000455	CcSEcCtD
Zoledronate—Abdominal pain—Epirubicin—sarcoma	3.68e-05	0.000455	CcSEcCtD
Zoledronate—Feeling abnormal—Doxorubicin—sarcoma	3.55e-05	0.000439	CcSEcCtD
Zoledronate—Gastrointestinal pain—Doxorubicin—sarcoma	3.52e-05	0.000436	CcSEcCtD
Zoledronate—Hypersensitivity—Epirubicin—sarcoma	3.43e-05	0.000424	CcSEcCtD
Zoledronate—Urticaria—Doxorubicin—sarcoma	3.42e-05	0.000423	CcSEcCtD
Zoledronate—Abdominal pain—Doxorubicin—sarcoma	3.4e-05	0.000421	CcSEcCtD
Zoledronate—Body temperature increased—Doxorubicin—sarcoma	3.4e-05	0.000421	CcSEcCtD
Zoledronate—Asthenia—Epirubicin—sarcoma	3.34e-05	0.000413	CcSEcCtD
Zoledronate—Pruritus—Epirubicin—sarcoma	3.29e-05	0.000407	CcSEcCtD
Zoledronate—Diarrhoea—Epirubicin—sarcoma	3.18e-05	0.000394	CcSEcCtD
Zoledronate—Hypersensitivity—Doxorubicin—sarcoma	3.17e-05	0.000393	CcSEcCtD
Zoledronate—Asthenia—Doxorubicin—sarcoma	3.09e-05	0.000382	CcSEcCtD
Zoledronate—Dizziness—Epirubicin—sarcoma	3.08e-05	0.000381	CcSEcCtD
Zoledronate—Pruritus—Doxorubicin—sarcoma	3.04e-05	0.000377	CcSEcCtD
Zoledronate—Vomiting—Epirubicin—sarcoma	2.96e-05	0.000366	CcSEcCtD
Zoledronate—Diarrhoea—Doxorubicin—sarcoma	2.94e-05	0.000365	CcSEcCtD
Zoledronate—Rash—Epirubicin—sarcoma	2.93e-05	0.000363	CcSEcCtD
Zoledronate—Dermatitis—Epirubicin—sarcoma	2.93e-05	0.000363	CcSEcCtD
Zoledronate—Headache—Epirubicin—sarcoma	2.91e-05	0.000361	CcSEcCtD
Zoledronate—Dizziness—Doxorubicin—sarcoma	2.85e-05	0.000352	CcSEcCtD
Zoledronate—Nausea—Epirubicin—sarcoma	2.76e-05	0.000342	CcSEcCtD
Zoledronate—Vomiting—Doxorubicin—sarcoma	2.74e-05	0.000339	CcSEcCtD
Zoledronate—Rash—Doxorubicin—sarcoma	2.71e-05	0.000336	CcSEcCtD
Zoledronate—Dermatitis—Doxorubicin—sarcoma	2.71e-05	0.000336	CcSEcCtD
Zoledronate—Headache—Doxorubicin—sarcoma	2.7e-05	0.000334	CcSEcCtD
Zoledronate—Nausea—Doxorubicin—sarcoma	2.56e-05	0.000317	CcSEcCtD
